Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000753

Director sold 35,473 shares at an average $18.63 ($660,888)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-08-07 Sale : show line 1 in the form −15,623 $18.53 $289,494 2,210,722 I
2017-08-08 Sale : show line 2 in the form −19,850 $18.71 $371,394 2,190,872 I
Open-market sales · 35,473 sh · avg $18.63 · $660,888
Loading xslF345X03/vonemster_fm4aug72017.xml…